A Shocking Cut to Chronic Disease Research: Will America's Health Suffer?
Last year, a wave of disheartening news swept through the scientific community as researchers across the nation received notifications that their vital grants had been abruptly canceled. The official explanation from the National Institutes of Health (NIH) director, Jay Bhattacharya, was that these grants were simply "clearing out the clutter," with no real connection to advancing the health of Americans. However, many experts found this reasoning unconvincing at the time, and now, compelling data has emerged to challenge this narrative.
A recent report from the Senate health committee has shed light on substantial reductions in funding for research into some of the most prevalent and deadly diseases in the United States. Over the past year, the NIH has significantly curtailed hundreds of grants dedicated to understanding and combating Alzheimer's, cancer, diabetes, and heart disease. These are precisely the conditions often highlighted by the "Make America Healthy Again" (MAHA) movement. Even Donald Trump, in his 2025 inauguration speech, pledged to "end the chronic disease epidemic," a sentiment echoed by Health and Human Services Secretary RFK Jr., who has emphasized the roles of nutrition and environment in health.
But here's where it gets controversial...
Considering RFK Jr.'s strong focus on "diet-related chronic disease," one might expect him to be a champion of researchers like Lisa Goldman Rosas, a Stanford epidemiologist. Rosas, who studies the intricate relationship between diet and human health, received one of those termination notices last spring, indicating her funding no longer aligned with administration priorities. She estimates that a staggering 1 million US deaths could be prevented annually with widespread adoption of healthy eating habits. Yet, her approach to achieving this goal seems to diverge from the administration's.
Rosas's work specifically targets Hispanic families, who face more than double the national average of food insecurity, a significant risk factor for numerous chronic conditions. "There’s really strong evidence that programs that promote healthy eating and active living need to be tailored to people’s cultural backgrounds. It’s not a one size fits all," she explained. This evidence-based perspective, focused on culturally sensitive interventions, became entangled in what some perceive as the administration's anti-DEI (Diversity, Equity, and Inclusion) stance, even though Rosas views it as simply "implementing patient-centered care."
And this is the part most people miss...
Numerous studies, even those with the most indirect links to DEI, have faced cancellation. An NIH employee, speaking anonymously for fear of reprisal, noted, "Anyone doing community outreach could have their research cut regardless of subject." This indiscriminate cutting, the employee warns, has a broad impact, limiting our collective understanding of human health and disease. "If you’ve been to the doctor, you’ve been impacted by NIH research," they added.
Rosas's research is highlighted in the Senate report alongside other critical chronic disease investigations that have been defunded. These include a 35-year study on Alzheimer's risk, a cancer vaccine development program, and a nutrition study described by an expert as "the most important study in nutrition that’s been done since vitamins."
Following the cancellation of her grant, Rosas had to halt patient recruitment and scramble to retain her team. The funding lapse also disrupted her crucial relationships with local farms that supplied food for her study. "It’s a waste of money to cut funding partway through a study," the NIH employee stated, emphasizing the serious safety implications for patients undergoing clinical trials when their treatments are interrupted.
Further analysis reveals that many of the hundreds of clinical trials halted last year were focused on chronic disease interventions, with about one-third specifically related to cancer treatment and prevention. Some of the most substantial grant terminations, as reported by Nature, were for cancer centers that offer advanced treatments not widely available elsewhere.
Rosas eventually managed to reinstate her funding through the assistance of her NIH program officer. However, due to staffing shortages and a hiring freeze, program officers are now managing significantly more work. Researchers seeking help with grant reinstatement may face long waits or find themselves reaching out to overwhelmed staff. By the time Rosas's grant was restored, she lamented, "a lot of the damage was unfortunately done."
While a federal judge's order reinstated another 2,000 NIH grants, over $700 million in grant money remains in uncertainty. Director Bhattacharya has indicated no inclination to release these funds, stating that restored DEI-related funding "will not be renewed." This policy will exacerbate the impact of reduced support for new grants. According to the Senate report, new funding for research on Alzheimer's, cancer, diabetes, and heart disease saw an overall decline of 16 percent in 2025, with Alzheimer's research bearing the brunt of the cuts. This is particularly concerning given the projected surge in Alzheimer's cases as the population ages.
Congress has pushed back against these drastic measures. In the recent budget bill, lawmakers rejected the president's proposal to halve biomedical research spending. The NIH received $47 billion for the upcoming year, a slight increase from the previous year.
Despite this congressional action, the NIH staffer anticipates continued administrative interference. "It’s no longer about what’s being cut but what’s being politicized and restricted now," they explained. "We got this full budget through, but how is that money going to be spent?"
What do you think? Is the administration's focus on certain research areas hindering progress on critical chronic diseases? Should funding decisions be solely based on scientific merit, or do political considerations play a necessary role? Share your thoughts in the comments below!
